38 reports

  • 6.1 INTRODUCTION
  • FUNCTIONAL FOOD INGREDIENTS MARKET SIZE, BY TYPE, 2016-2023 (USD MILLION)

PREBIOTICS RESIST GASTRIC ACIDITY AND HYDROLYSIS CAUSED BY ENZYMES AND GASTROINTESTINAL ABSORPTION.

  • Mineral Supplement
  • United States
  • Market Size
  • Arla Foods
  • Cargill Inc.

One of the major reasons for the high bioavailability of organic minerals is that, unlike inorganic minerals, these do not interact with fiber, tannin, phytate, silicates, oxalate, or other minerals in the gastrointestinal tract.

  • Mineral Supplement
  • Pig
  • World
  • Alltech Inc.
  • Kemin Industries, Inc.

THE MICROPEARLS SPRAY FREEZING TECHNOLOGY ALLOWS FOR THE TIMELY RELEASE OF THESE ## KEY NUTRIENTS THROUGHOUT AN ANIMAL' S GASTROINTESTINAL TRACT.

  • Mineral Supplement
  • North America
  • United States
  • World
  • Market Size
  • VITAMIN & MINERAL PREMIXES MARKET, BY FUNCTIONALITY

Q. ##.

  • Mineral Supplement
  • World
  • Market Size
  • Glanbia plc
  • Nutreco N.V.

MARKET ##.

  • Mineral Supplement
  • APAC
  • Japan
  • World
  • Demand
  • 7.1 Nutrition/Therapeutic

TABLE OF CONTENTS ##.

  • Mineral Supplement
  • Archer Daniels Midland Company
  • Boehringer Ingelheim GmbH
  • Darling Ingredients Inc.
  • DuPont

You can easily book an appointment with one online.

  • Mineral Supplement
  • World
  • Market Size
  • Alltech Inc.
  • Kemin Industries, Inc.

By the year 2040, ## adult in ## will have diabetes.

  • Insulin Delivery
  • Type 1 Diabetes
  • World
  • Market Size
  • Animas Corporation

It is used to enhance rumen and gastrointestinal tract function.

  • Cattle
  • Mineral Supplement
  • World
  • Market Size
  • Nutreco N.V.

Dietary fibers can act by changing the nature of the contents of the gastrointestinal tract and by changing how other nutrients and chemicals are absorbed.

  • Mineral Supplement
  • China
  • Demand
  • Amway Corporation
  • Joincare Pharmaceutical Group Industry Co., Ltd.
  • Pipeline analysis

Sotagliflozin is a small molecule and exhibits its mechanism by inhibiting SGLT-##, which helps absorb glucose and galactose in the gastrointestinal (GI) tract, and SGLT-##, which helps in glucose reabsorption by the kidney.

  • Type 1 Diabetes
  • World
  • Eli Lilly & Co.
  • Novo Nordisk Group
  • Sanofi S.A.

Dietary fibers can act by changing the nature of the contents of the gastrointestinal tract and by changing how other nutrients and chemicals are absorbed.

  • Energy
  • Mineral Supplement
  • Vitamin
  • China
  • Demand

MARKET SEGMENTATION ##.

  • Mineral Supplement
  • Argentina
  • Croda International Plc
  • Danone SA
  • General Mills, Inc.

The alleviation of gastrointestinal morbidity and other diseases in livestock, such as swine dysentery and acidosis in ruminants, is another advantage of feed ingredients enzymes.

  • Mineral Supplement
  • Colombia
  • South America
  • Market Size
  • Alltech Inc.

It is estimated that worldwide one in five men and one in three women are at risk of an osteoporotic fracture.

  • Mineral Supplement
  • World
  • Forecast
  • Quidel Corporation
  • Roche Group

The subsidiary is focused on aging care, critical care & surgery, gastrointestinal function, and pediatrics.

  • Mineral Supplement
  • North America
  • United States
  • Demand
  • Market Size

Q. ##.

  • Mineral Supplement
  • United States
  • Cargill Inc.
  • Koninklijke DSM N.V.
  • Nutreco N.V.

IN THE PHASE III TRIALS OF VICTOZA IN T##D PATIENTS, THE MOST FREQUENTLY REPORTED ADVERSE EVENTS WERE GENERALLY MILD OR MODERATE AND GASTROINTESTINAL IN NATURE.

  • Type 1 Diabetes
  • Eli Lilly & Co.
  • Lantus group
  • Novo Nordisk Group
  • Sanofi S.A.

IN THE PHASE III TRIALS OF VICTOZA IN T##D PATIENTS, THE MOST FREQUENTLY REPORTED ADVERSE EVENTS WERE GENERALLY MILD OR MODERATE AND GASTROINTESTINAL IN NATURE.

  • Type 1 Diabetes
  • Eli Lilly & Co.
  • Lantus group
  • Novo Nordisk Group
  • Novolin R group

IN THE PHASE III TRIALS OF VICTOZA IN T##D PATIENTS, THE MOST FREQUENTLY REPORTED ADVERSE EVENTS WERE GENERALLY MILD OR MODERATE AND GASTROINTESTINAL IN NATURE.

  • Type 1 Diabetes
  • Eli Lilly & Co.
  • Lantus group
  • Novo Nordisk Group
  • Novolin R group

IN THE PHASE III TRIALS OF VICTOZA IN T##D PATIENTS, THE MOST FREQUENTLY REPORTED ADVERSE EVENTS WERE GENERALLY MILD OR MODERATE AND GASTROINTESTINAL IN NATURE.

  • Type 1 Diabetes
  • Eli Lilly & Co.
  • Lantus group
  • Novo Nordisk Group
  • Novolin R group

IN THE PHASE III TRIALS OF VICTOZA IN T##D PATIENTS, THE MOST FREQUENTLY REPORTED ADVERSE EVENTS WERE GENERALLY MILD OR MODERATE AND GASTROINTESTINAL IN NATURE.

  • Type 1 Diabetes
  • Eli Lilly & Co.
  • Lantus group
  • Novo Nordisk Group
  • Novolin R group

It provides products across various therapeutic areas including hematology, neuroscience, immunology, genetic disease, ophthalmic, gastrointestinal, endocrine, hereditary angioedema, cancer and other diseases.

  • Endocrine Disease
  • Mineral Supplement
  • United States
  • World
  • Product Initiative

NIHS' research categories comprise brain health, molecular nutrition, system science, cell biology, mitochondrial function, omics, informatics, cognitive health and ageing, metabolic health, and gastrointestinal health.

  • Cell Therapy
  • Type 1 Diabetes
  • United States
  • Company Operations
  • ViaCyte, Inc.
  • 06/05/2017: Lexicon Pharmaceuticals To Present New Clinical Data At 77th American Diabetes Association Scientific Sessions
  • Sep 05, 2017: Lexicon Pharmaceuticals to Present New Clinical Data at the European Association for the Study of Diabetes 53rd Annual Meeting

Most carcinoid tumors are found in the gastrointestinal tract.

  • Mineral Supplement
  • Pharmaceutical
  • Type 1 Diabetes
  • United States
  • Lexicon Pharmaceuticals, Inc.
  • SYNTHETIC PEPTIDE TO AGONIZE NK1 FOR TYPE 1 DIABETES - DRUG PROFILE
  • COMPUGEN LTD

Its pipeline candidates are used to treat the gastrointestinal and CRC and orphan diseases.

  • Chronic Disease
  • Mineral Supplement
  • Type 1 Diabetes
  • United States
  • Company

Early in January 2018, Adocia had also announced the expansion of the BioChaperone technology platform to enable the development of innovative treatments in the gastrointestinal (BioChaperone GLP-##) and obesity (BioChaperone Glucagon GLP-##) fields.

  • Insulin
  • Type 1 Diabetes
  • China
  • Company
  • Adocia

Inflammatory bowel disease (IBD) is one of the most functional gastrointestinal disorders, caused due to abnormal immune response.

  • Immunochemistry Test
  • Type 1 Diabetes
  • World
  • Market Size
  • Thermo Fisher Scientific, Inc.
  • 1.1 MARKET DEFINITION

Such drugs with sensorial effects are mainly developed in the cough, cold & allergy and gastrointestinal categories.

  • Mineral Supplement
  • OTC
  • Spain
  • Forecast
  • Sanofi S.A.

The Minimally Invasive Therapies Group (MITG) includes the Surgical Innovations (SI) and the Respiratory, Gastrointestinal & Renal (RGR) divisions.

  • Clinical Trial
  • Endocrine Disease
  • Insulin Delivery
  • Type 1 Diabetes
  • Medtronic, Inc.